Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
10/2003
10/30/2003WO2003000877A3 A soluble complex comprising a retroviral surface glycoprotein
10/30/2003WO2002098370A3 Methods of administering/dosing cd2 antagonists for the prevention and treatment of autoimmune disorders or inflammatory disorders
10/30/2003WO2002097030A3 Peptides derived from neural thread proteins and their medical use
10/30/2003WO2002085941A3 Modified interferon alpha with reduced immunogenicity
10/30/2003WO2002074330A3 Mycobacterrial estracts for treating autoimmune diseases
10/30/2003WO2002069961A8 Il-8 receptor ligands-drugs for inflammatory and autoimmune diseases
10/30/2003WO2002066476A9 6-phenylbenzonaphthyridines
10/30/2003WO2002059283A3 Nucleic acid modification enzymes
10/30/2003WO2002056909A3 Method for inducing an immune response to polysaccharide bacterial antigens and to protein structures of virus capsids
10/30/2003WO2002042303A3 Acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4-diaminocyclohexyl)-purines and their use as antiproliferative agents
10/30/2003WO2002034783A3 Transmembrane proteins
10/30/2003WO2002032447A3 Cell damage inhibitor
10/30/2003WO2002028429A9 Modulation of allergic response
10/30/2003WO2002018583A9 Modified polypeptides stabilized in a desired conformation and methods for producing same
10/30/2003WO2002002638A3 Methods for treating rheumatic diseases using a soluble ctla4 molecule
10/30/2003WO2001085154A8 Method of treating immune pathologies with low dose estrogen
10/30/2003US20030204089 Enantiomers of 1-[(4-chlorophenyl) phenylmethyl]-4-[(4-methylphenyl) sulfonyl] piperazine
10/30/2003US20030204086 Novel heterocyclic amide derivatives
10/30/2003US20030204065 Comprises peptidoglycan recognition protein (PGRP) for diagnosis and treatment of blood and tumor disorders
10/30/2003US20030204052 Comprises polypeptide for treatment and prevention of autoimmune, cancer, inflammatory, nervous system, cardiomyopathy and atherosclerotic disorders
10/30/2003US20030203955 Administering to a patient suffering from an immune cell mediated diseases a therapeutic amount of biheterocyclic compound containing sulfone group or substituted suflone
10/30/2003US20030203951 Aromatic or heteroaromatic compounds containing amide group are useful as inhibitor of dihydroorotate dehydrogenase
10/30/2003US20030203926 For treatment of inflammatory or autoimmune condition, viral infection, cancer
10/30/2003US20030203924 Combination for treating susceptible tumor comprising (S)-2-(5-(((1,2-dihydro-3-methyl-1-oxobenzo(f) quinazolin-9-yl)methyl)amino)-1-oxo-2-isoindolinyl)glutaric acid and folic acid
10/30/2003US20030203922 Substituted amine derivatives and methods of use
10/30/2003US20030203919 Dipeptide nitrile cathepsin K inhibitors
10/30/2003US20030203915 Compounds that are nitrosated and/or nitrosylated through one or more sites such as oxygen (hydroxyl condensation), sulfur (sulfhydryl condensation) and/or nitrogen
10/30/2003US20030203909 A N-phenyl-benzo(b)thiophene-carboxamide derivatives, as enzyme inhibitor of tyrosine kinase; antiproliferation of lymphocyte, treating autoimmune disease, rheumatic disease, as immunosuppressant, antiinflammatory agents
10/30/2003US20030203905 Inhibitors of p38
10/30/2003US20030203897 2,4-Disubstituted thiazolyl derivatives
10/30/2003US20030203893 Benzimidazole derivatives, preparation and therapeutic use thereof
10/30/2003US20030203882 For treating psoriasis, inflammation, leukemia, colon cancer, breast cancer or prostate cancer
10/30/2003US20030203855 17-Aryl linker derivatised estrogen 3-sulphamates as inhibitors of steroid sulphatase
10/30/2003US20030203852 Acyl pseudodipeptides which carry a functionalised auxialiary arm
10/30/2003US20030203484 Inducing differentiation of isolated marrow stromal cell into a neuronal cell using neuronal differentiation-inducing compound such as dimethylsulfoxide and butylated hydroxyanisole for treating nervous system disorders
10/30/2003US20030203452 Human chemokine beta-13
10/30/2003US20030203396 Human galactosyltransferases
10/30/2003US20030203052 Superoxide dismutase-containing cucumber extract coated and/or microencapsulated in a fat-soluble agent based on a fatty substance can be used by the topical or oral route; antiallergens; sunscreen agents; foods; drugs; cosmetics
10/30/2003US20030203030 Polymeric gel delivery system for pharmaceuticals
10/30/2003US20030203020 Pharmaceutical compositions for piperidinoalkanol compounds
10/30/2003US20030203003 Drug releasing biodegradable fiber implant
10/30/2003US20030202991 Delivery of biologically active polypeptides
10/30/2003US20030202988 Attenuated mutant; induce immunology response
10/30/2003US20030202975 Using monoclonal antibodies; shrinkage of solid tumors
10/30/2003US20030202961 Methods of therapy for HIV infection
10/30/2003EP1496982A2 Solid forms of salts with tyrosine kinase activity
10/30/2003CA2770411A1 Aerosol containing a particulate active substance
10/30/2003CA2484384A1 Preventives for hiv infection
10/30/2003CA2483409A1 (20s)-1.alpha.-hydroxy-2.alpha.-methyl and 2.beta.-methyl-19-nor-vitamin d3 and their uses
10/30/2003CA2483327A1 Oligonucleotides from coding sequences for the surface component of ptlvenvelope proteins and uses thereof
10/30/2003CA2482991A1 Imidazo[1,2-a]pyrazin-8-ylamines method of making and method of use thereof
10/30/2003CA2482924A1 Adjuvant enhanced immunotherapy
10/30/2003CA2482907A1 Tissue specific genes and gene clusters
10/30/2003CA2482717A1 Polymorph of ascomycin derivative
10/30/2003CA2482260A1 Use of heme oxygenase-1 and products of heme degradation
10/30/2003CA2482183A1 Method of treating biological materials with translating electrical fields and electrode polarity reversal
10/30/2003CA2482022A1 Novel compounds
10/30/2003CA2481940A1 (1-4-piperidinyl) benzimidazole derivatives useful as histamine h3 antagonists
10/30/2003CA2480404A1 Fc receptor homolog, reagents, and uses thereof
10/30/2003CA2480325A1 Solid forms of salts with tyrosine kinase activity
10/29/2003EP1357131A2 Treatment of lupus nephritis with anti-CD4OL compounds
10/29/2003EP1357120A1 2-(2,6-dioxopiperidin-3-yl)isoindoline derivatives, their preparation and their use as inhibitors of inflammatory cytokines
10/29/2003EP1357114A1 Substituted pyrimidin-2,4(1H,3H)-diones as inhibitors of Matrix Metalloproteinases (MMP)
10/29/2003EP1357111A1 Pyridone derivative having affinity for cannabinoid 2-type receptor
10/29/2003EP1357104A1 Tropolone derivative
10/29/2003EP1356826A1 Microparticles comprising carbohydrate beads covalently linked with allergen
10/29/2003EP1356822A2 Pharmaceutical compositions enhancing the immunogenicity of poorly immunogenic antigens
10/29/2003EP1356818A2 Drug, in particular for modulating the immunological response for the control of viruses, tumours, bacteria and parasites
10/29/2003EP1356288A1 Screening assay for cotranslational translocation interfering compounds
10/29/2003EP1356092A2 Compositions and methods for the therapy and diagnosis of ovarian cancer
10/29/2003EP1356071A2 Genetically engineered herpes virus for the treatment of cardiovascular disease
10/29/2003EP1356047A2 Human proteins, polynucleotides encoding them and methods of using the same
10/29/2003EP1356046A2 Cytokine receptor zcytor19
10/29/2003EP1356043A2 Novel proteins and nucleic acids encoding same and antibodies directed against these proteins
10/29/2003EP1356042A2 Carbohydrate-associated proteins
10/29/2003EP1356032A2 Human kinases
10/29/2003EP1356028A2 Protein modification and maintenance molecules
10/29/2003EP1355945A2 Flint glycoforms
10/29/2003EP1355939A2 Interferons, uses and compositions related thereto
10/29/2003EP1355935A2 Secreted proteins
10/29/2003EP1355923A2 Immunomodulatory peptides derived from heat shock proteins and uses thereof
10/29/2003EP1355922A2 Stress proteins and peptides and methods of use thereof
10/29/2003EP1355919A2 Molecules with extended half-lives, compositions and uses thereof
10/29/2003EP1355910A1 Formulation of boronic acid compounds
10/29/2003EP1355909A2 Dihydropyrazolopyridine compounds and pharmaceutical use thereof
10/29/2003EP1355907A1 Thiazolyl-, oxazolyl-, pyrrolyl-, and imidazolyl-acid amide derivatives useful as inhibitors of pde4 isozymes
10/29/2003EP1355905A1 Pyrazole compounds useful as protein kinase inhibitors
10/29/2003EP1355892A1 2-amino-4-(pyridin-2-yl)-thiazole derivatives as transforming growth factor beta (tgf-beta) inhibitors
10/29/2003EP1355888A1 Quinazolinone derivatives
10/29/2003EP1355885A1 Pyridine derivatives useful as cyclooxygenase inhibitor
10/29/2003EP1355884A1 Nicotinamide biaryl derivatives useful as inhibitors of pde4 isozymes
10/29/2003EP1355877A1 Process of obtaining compositions of stable lutein and lutein derivatives
10/29/2003EP1355875A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists
10/29/2003EP1355870A1 Thiazolamines and their use as tgf-beta inhibitors
10/29/2003EP1355673A2 Multivalent meningococcal polysaccharide-protein conjugate vaccine
10/29/2003EP1355666A2 Use of rgm and its modulators
10/29/2003EP1355653A2 Stimulation of thymus for vaccination development
10/29/2003EP1355649A2 Pharmaceutical formulation containing pyrazolo 4,3-d]pyrimidine and nitrates or thienopyrimidines and nitrates
10/29/2003EP1355645A2 Method for treating fibrotic diseases or other indications iiic
10/29/2003EP1355643A2 Epoxyvibsanin b
1 ... 675 676 677 678 679 680 681 682 683 684 685 686 687 688 689 690 691 692 693 694 695 ... 1172